BioSpace News Archive

Press Releases

First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure

July 13, 2026
·
3 min read
Press Releases

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

July 13, 2026
·
7 min read
Press Releases

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors

July 13, 2026
·
4 min read
Press Releases

Servier completes the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business

July 13, 2026
·
2 min read
Press Releases

Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

July 13, 2026
·
9 min read
Press Releases

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

July 13, 2026
·
10 min read
Press Releases

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

July 13, 2026
·
5 min read
Press Releases

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

July 13, 2026
·
7 min read
Press Releases

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

July 13, 2026
·
7 min read
Press Releases

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

July 13, 2026
·
1 min read